Ibudilast and Withdrawal-Related Dysphoria
Withdrawal-Related Dysphoria as a Moderator of Ibudilast for Alcohol Use Disorder
Sponsor: University of California, Los Angeles
A PHASE2 clinical study on Alcohol Use Disorder, this trial is completed. The trial is conducted by University of California, Los Angeles and has accumulated 12 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE2
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE2
-
Nov 2021 — Dec 2022 [monthly]
Completed PHASE2
▶ Show 7 earlier versions
-
Jan 2021 — Nov 2021 [monthly]
Completed PHASE2
-
Dec 2020 — Jan 2021 [monthly]
Completed PHASE2
Status: Recruiting → Completed
-
Nov 2019 — Dec 2020 [monthly]
Recruiting PHASE2
-
Sep 2018 — Nov 2019 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Aug 2018 — Sep 2018 [monthly]
Not Yet Recruiting PHASE2
-
Jun 2018 — Aug 2018 [monthly]
Not Yet Recruiting PHASE2
-
May 2018 — Jun 2018 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of California, Los Angeles
For direct contact, visit the study record on ClinicalTrials.gov .